1 | Dupilumab (D10354) | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
(D10354) 💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [5] 51 51, 97, 98, 160, 162 💬
|
2 | Dupilumab 300MG solution FOR injection (D10354) | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
(D10354) 💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 51 51 💬
|
3 | Dupilumab injection (D10354) | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
(D10354) 💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 160 160 💬
|
4 | Dupilumab prefilled syringe (D10354) | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
(D10354) 💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 160 160 💬
|